Results 111 to 120 of about 10,258 (173)

Editorial: EBV strategies to counteract the immune response. [PDF]

Front Immunol
Lazzi S, Bellan C, Chabay P, Khoueiry R, Mundo L, Murray P.   +5 more
europepmc   +1 more source

Designing universal T cell therapies: strategies to evade natural killer cells. [PDF]

Front Immunol
Bushara O, Linette GP, Carreno BM.
europepmc   +1 more source

Scalable generation of hematopoietic stem cell-engineered off-the-shelf mono-specific cytotoxic T cells targeting solid tumors. [PDF]

Cell Rep Med
Zhu Y, Yu J, Kim YJ, Tian Y, Li Z, Chen Y, Lyu Z, Zhu E, Zhao AS, Ma N, Zhang C, Kramer A, Wilson M, Hon R, Wang YC, Lin S, Shen X, Hahn Z, Zhang Y, Wang A, Li YR, Yang L.   +21 more
europepmc   +1 more source

Iterative multiplex imaging cytometry for cross-species analyses of in situ tissue leukocytes. [PDF]

J Immunol Methods
Balachandran H, Manickam C, Jones R, Kroll K, Afifi A, Pruitt A, Wong M, Rascle P, Woolley G, Blair R, Scheef E, Kwun J, Permar S, Kaur A, Reeves RK.   +14 more
europepmc   +1 more source

Differentiation of cord blood-derived Innate Lymphoid Cells 1  into KIR+NKG2A- natural killer cells in a human stem cell niche. [PDF]

Stem Cells Transl Med
Bennstein SB, Reiß J, Weinhold S, Scherenschlich N, Degistirici Ö, Raba K, Walter L, Fischer JC, Kögler G, Meisel R, Uhrberg M.   +10 more
europepmc   +1 more source

Coevolution of NK and Tumor Cell States Along Multiple Myeloma Progression from Precursor Conditions. [PDF]

Int J Mol Sci
Aquilina C, Romano A, Corsale AM, Biondo M, Speciale M, Tofacchi E, Di Simone M, Gigliotta E, Dieli C, Avellone C, Toscano A, Camarda L, Romano A, Cambria D, Giavaresi G, Raimondi L, Neri A, Campana S, Caccamo N, Dieli F, Siragusa S, Meraviglia S, Botta C.   +22 more
europepmc   +1 more source

The CD94/NKG2A-HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective. [PDF]

Clin Cancer Res
López-Botet M, Vilches C, Muntasell A.
europepmc   +1 more source

Natural Killer Cell Plasticity in Epithelial Ovarian Cancer and Their Therapeutic Implications. [PDF]

Cells
Onuma T, Asare-Werehene M, Orisaka M, Tsang BK.   +3 more
europepmc   +1 more source

A fully human pan VL9 HLA-E TCRm antibody enables functional dissection of HLA-E biology and checkpoint signaling. [PDF]

iScience
Ghaffari S, Upchurch-Ange K, Oter G, Tripathi T, Gimlin S, Wawro Weidanz D, Middelburg J, van Hall T, Weidanz JA.   +8 more
europepmc   +1 more source

High IL-10 levels during CRS are negatively associated with NK-cell recovery after CAR-T cell therapy. [PDF]

Clin Transl Immunology
Wang X, Luo W, Li Y, Wu J, Tang L, Li C, Liu Q, Chen Z, Hu Y, Mei H.   +9 more
europepmc   +1 more source